General Information of the Compound
Compound ID
CP0867451
Compound Name
(3S)-4-[[(9R,15S,18S,21S,24S,30S,33S,36R,39S,42S,48S,51S,54S,57S,60R)-24-(2-amino-2-oxoethyl)-60-[[(2S)-1-amino-1-oxopropan-2-yl]carbamoyl]-51-(carboxymethyl)-57-[(1R)-1-hydroxyethyl]-42-(1H-imidazol-4-ylmethyl)-54-(1H-indol-3-ylmethyl)-18,33,39-tris(2-methylpropyl)-4,10,16,19,22,25,31,34,37,40,43,49,52,55,58,65,68-heptadecaoxo-21-propan-2-yl-7,62,71-trithia-1,3,11,17,20,23,26,32,35,38,41,44,50,53,56,59,66-heptadecazahexacyclo[34.31.5.13,66.011,15.026,30.044,48]triheptacontan-9-yl]amino]-3-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-4-oxobutanoic acid
    Show/Hide
Structure
Formula
C104H158N30O28S3
Molecular Weight
2372.791
Canonical SMILES
CC(C)C[C@@H]1NC(=O)[C@@H]2CSCCC(=O)N3CN(CN(C3)C(=O)CCSC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)N2)C(=O)CCSC[C@@H](C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]cn2)NC1=O
    Show/Hide
InChI
InChI=1S/C104H158N30O28S3/c1-51(2)34-63-88(147)122-69(38-59-43-110-47-113-59)101(160)132-28-15-22-75(132)98(157)121-68(41-82(142)143)90(149)117-66(37-58-42-112-61-19-13-12-18-60(58)61)93(152)128-84(57(11)135)100(159)125-71(94(153)114-56(10)85(107)144)44-163-31-24-78(137)129-48-130-50-131(49-129)80(139)26-33-165-46-73(126-91(150)67(40-81(140)141)118-87(146)62(115-86(145)55(9)105)20-14-27-111-104(108)109)103(162)134-30-17-23-76(134)97(156)120-65(36-53(5)6)92(151)127-83(54(7)8)99(158)123-70(39-77(106)136)102(161)133-29-16-21-74(133)96(155)119-64(35-52(3)4)89(148)124-72(95(154)116-63)45-164-32-25-79(130)138/h12-13,18-19,42-43,47,51-57,62-76,83-84,112,135H,14-17,20-41,44-46,48-50,105H2,1-11H3,(H2,106,136)(H2,107,144)(H,110,113)(H,114,153)(H,115,145)(H,116,154)(H,117,149)(H,118,146)(H,119,155)(H,120,156)(H,121,157)(H,122,147)(H,123,158)(H,124,148)(H,125,159)(H,126,150)(H,127,151)(H,128,152)(H,140,141)(H,142,143)(H4,108,109,111)/t55-,56-,57+,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,83-,84-/m0/s1
    Show/Hide
InChIKey
SUKQBHRYEGBQMC-QAMXRMFNSA-N
Physicochemical Property
logP
-7.19423
Rotatable Bonds
31
Heavy Atom Count
165
Polar Areas
871.76
Hydrogen Bond Donor Count
26
Hydrogen Bond Acceptor Count
32
Complexity
165

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 156017810
ChEMBL ID
CHEMBL4643893
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01335, Ephrin type-A receptor 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 6.8 nM
   TI
   LI
   LO
   TS